StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Investment analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Wednesday. The firm set a “buy” rating on the stock.

Mannatech Trading Down 0.4 %

NASDAQ:MTEX opened at $8.96 on Wednesday. The stock has a fifty day simple moving average of $11.13 and a 200 day simple moving average of $10.05. The firm has a market capitalization of $16.90 million, a price-to-earnings ratio of -11.07 and a beta of 1.06. Mannatech has a 1-year low of $6.75 and a 1-year high of $16.49. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44.

Mannatech (NASDAQ:MTEX) last announced its earnings results on Wednesday, March 26th. The company reported $1.20 EPS for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The company had revenue of $29.01 million during the quarter.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.